Search

everythinglearnresearchcommunity

for

Search:↓

The study concludes that early diagnosis of Frontal Fibrosing Alopecia is important, as it is often found in postmenopausal women, may be related to Lichen Planopilaris, and eyebrow hair loss is a common sign.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Hair transplantation can effectively restore hair in patients with stable lichen planopilaris or frontal fibrosing alopecia.

High-frequency ultrasound effectively evaluates and diagnoses frontal fibrosing alopecia.

Accurate diagnosis of basaloid follicular hamartoma is crucial to avoid unnecessary treatments.

The LEF-1 binding site enhances gene expression in hair follicles, with other proteins aiding specific regulation.

Lower dosages of 2-(difluoromethyl)-dl-ornithine might reduce side effects, supporting further research.

Antimalarial agents are effective for LPP, and intralesional steroids are effective for FFA.

TCF/Lef1 activity is essential for proper skin cell development and renewal.

Using facial sunscreen and moisturizer may increase the risk of frontal fibrosing alopecia.

Lipid nanoparticles improve treatment delivery and are key to future therapies, but challenges in manufacturing and safety remain.

Fibronectin-attached cell sheets improve wound healing and are safe and effective.

Sugar molecule helps hair growth, less in balding, returns with treatment.

Fluridil promotes hair growth safely and effectively for androgenetic alopecia.

Researchers developed a new method to clearly see and label hair proteins with minimal errors using advanced freezing and microscopy techniques.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

Laser microdissection helps get DNA from single hair follicles for better forensic analysis.

Videodermoscopy better identifies female hair loss than clinical diagnosis.

Avoiding certain allergens in personal care products may improve symptoms for some patients with lichen planopilaris or frontal fibrosing alopecia.

Inflammation and immune responses contribute to female pattern hair loss.

Most patients with frontal fibrosing alopecia stabilized with treatment, especially younger ones, using intralesional corticosteroids and tacrolimus.

Certain skin proteins can form anchoring structures without the protein AMACO.

Frontal Fibrosing Alopecia is a poorly understood condition that is hard to treat and causes distressing hair loss.

Finasteride may help treat frontal fibrosing alopecia, but more research is needed.

More research needed to confirm finasteride as standard treatment for FFA.

Lychnophora salicifolia extract in liposomes may protect skin from UV damage and inflammation.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

Frontal fibrosing alopecia may be caused by an autoimmune reaction and hormonal imbalance.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.